FDAnews

EC PRAISES ADVENT OF BIOSIMILARS

With Novartis' application to market a generic version of Pfizer's Genotropin in the EU having recently been approved, the European Commission has voiced its support for biosimilars. Two decades after the first drugs produced by biotechnological means arrived on the EU market, a number of these patents are expiring.

Pharmaceutical Business Review (http://www.pharmaceutical-business-review.com/article_news.asp?guid=7FF640E5-5EE6-43A0-A2E7-8BE06C7D38E4)